We are interested in understanding how the genome functions and using this to develop advanced cellular therapies
The lab has expertise in developing high thoughput sequencing based assays, particularly to interrogate the 3D genome
We also have experience in genome editing and are interested in developing strategies of editing cells to treat human disease
In higher eukaryotes many genes are controlled by regulatory elements called enhancers, which are often located hundreds of thousands of base pairs distant from the gene. Enhancers contain small sequences (~10bp) which bind transcription factors and these make physical contact with the proteins at the promoter to activate gene expression. Until recently, we have had limited ability to define the detail of physical contacts that control genes below 1kb resolution. We have recently developed a new method (Micro Capture-C) to define genome architecture in unprecedented detail (down to base pair resolution). We are using the new technique to study the fundamental mechanisms of gene regulation and to define how variation in genome sequence links to human disease.
A lot of the high throughput sequencing based assays we develop are challenging to analyse and we often have to write completely novel software to analyse the data.
The lab also has expertise in cutting edge genome editing technology. James Davies is a haematologist with a specialist interest in bone marrow transplantation and cellular therapy. At present, we are working with biotech to bring genome editing approaches we have developed for treating thalassaemia and sickle cell disease into the clinic.
Here are some of latest projects.
Click on the images to make them bigger
We're always keen to hear from people who are interested in our science!
Please get in touch